Lisa Dilworth

Lisa Dilworth has extensive work experience in the pharmaceutical and biotech industry. Lisa is currently serving as the Vice President of Disease Monitoring Programs at Ultragenyx Pharmaceutical Inc. Prior to this, they held roles as Vice President of Integrated Strategic Solutions and Vice President and Head of Operations at Parexel. Lisa also worked as an independent contractor, where they served as a Clinical Scientist and Clinical Strategist. Lisa has held various Vice President positions at Synteract and worked as the Director of Therapeutic Expertise, Scientific Affairs, Rare Disease at PRA Health Sciences. Lisa has also worked at UCB, Chiltern International, Kendle International, PPD, and James R Nelson, MD, gaining experience in clinical research, neurophysiology, and study coordination.

Lisa Dilworth earned a Bachelor's Degree in Integrative Biology/Human Biodynamics from the University of California, Berkeley from 2000 to 2005. Lisa later pursued a Master's degree in Clinical Research at UC San Diego, from 2008 to 2009.